Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema

Eri Ito, Yoshinao Muro, Akitaka Shibata, Kazumitsu Sugiura, Masashi Akiyama

研究成果: Article

1 引用 (Scopus)

抜粋

Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder.

元の言語English
ジャーナルDermatology Online Journal
20
発行部数8
出版物ステータスPublished - 2014
外部発表Yes

    フィンガープリント

All Science Journal Classification (ASJC) codes

  • Dermatology

これを引用